» Articles » PMID: 9175614

Adenosine A3 Receptors Potentiate Hippocampal Calcium Current by a PKA-dependent/PKC-independent Pathway

Overview
Specialties Neurology
Pharmacology
Date 1997 Mar 1
PMID 9175614
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The modulation of high-threshold Ca current (I(Ca)) by adenosine receptors was studied using the voltage clamp method on acutely dissociated guinea pig hippocampal CA3 pyramidal neurons. When these neurons were exposed to adenosine in the presence of A1, A2a and A2b receptor antagonists, I(Ca) potentiation occurred at test potentials of -10 mV, but not at -40 mV. Similar potentiation also occurred using the A3 agonist N6-2-(4-aminophenyl)ethyl-adenosine (APNEA), either alone or in the presence of A1 and A2 antagonists. The putative A4 agonist 2-phenylaminoadenosine (CV-1808; Cornfield et al., 1992) did not potentiate I(Ca) at four concentrations tested between 25 nM and 2500 nM. K0.5 for the APNEA-induced potentiation was 25.4 nM, comparable to that determined in binding studies for the cloned receptor (15.5 nM; Zhou et al., 1992). I(Ca) potentiation by APNEA was blocked by intracellular application of WIPTIDE, a PKA inhibitor (p < 0.001), but was not affected by protein kinase C (PKC) inhibitor peptide (19-36). These results indicate that: (1) A3 receptor activation can significantly potentiate I(Ca), and (2) because the A3 receptor has been linked to down-regulation of adenylyl cyclase (Zhou et al., 1992), PKA appears to be negatively coupled to I(Ca).

Citing Articles

A "Dock-Work" Orange: A Dual-Receptor Biochemical Theory on the Deterrence Induced by Citrusy Aroma on Elephant Traffic Central to a Conservation Effort.

Gunawardana D Bioinform Biol Insights. 2025; 19:11779322251315922.

PMID: 40026377 PMC: 11869256. DOI: 10.1177/11779322251315922.


Therapeutic Potential of Highly Selective A Adenosine Receptor Ligands in the Central and Peripheral Nervous System.

Coppi E, Cherchi F, Venturini M, Lucarini E, Corradetti R, Di Cesare Mannelli L Molecules. 2022; 27(6).

PMID: 35335254 PMC: 8952202. DOI: 10.3390/molecules27061890.


The Anti-Cancer Effect of A Adenosine Receptor Agonists: A Novel, Targeted Therapy.

Fishman P, Jacobson K, Ochaion A, Cohen S, Bar-Yehuda S Immunol Endocr Metab Agents Med Chem. 2021; 7:298-303.

PMID: 34824647 PMC: 8611655. DOI: 10.2174/187152207781369878.


A Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.

Jacobson K, Moro S, Kim Y, Li A Drug Dev Res. 2019; 45(3-4):113-124.

PMID: 31808655 PMC: 6893906. DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<113::AID-DDR5>3.0.CO;2-S.


The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Pedata F, Melani A, Pugliese A, Coppi E, Cipriani S, Traini C Purinergic Signal. 2008; 3(4):299-310.

PMID: 18404443 PMC: 2072927. DOI: 10.1007/s11302-007-9085-8.